Can a traumatic brain injury cause migraine headaches?

Can Head Injury Cause Migraine?

Yes, head injury can definitively cause migraine headaches, with post-traumatic headache (PTH) being one of the most common sequelae following traumatic brain injury (TBI), affecting approximately 49% of patients who sustain head trauma 1.

Epidemiology and Risk

The relationship between head trauma and migraine is well-established:

• Nearly half of TBI survivors develop chronic headache, with post-traumatic headache representing the most prevalent pain syndrome 2
• Patients with mild TBI (mTBI) have a 1.48-fold increased risk of developing migraine compared to those without TBI 3
• Major trauma (Injury Severity Score ≥16) carries an even higher risk (adjusted HR: 1.670) compared to minor trauma 3
• Up to 34-44% of concussion patients experience persistent symptoms at 3-6 months, with 5-20% still symptomatic at 12 months 4

Clinical Phenotype

The migraine-like phenotype dominates post-traumatic headache presentations:

• In prospective diary studies, 73% of patients with persistent PTH had chronic migraine-like headaches 5
• When considering only moderate-to-severe headache days, 55% were exclusively migraine-like 5
• Only 13% had pure tension-type headache phenotype 5

Patients with mTBI history and migraine show distinct clinical features compared to primary migraine alone 6:

• Higher rates of chronic migraine (74.3% vs 65.8%)
• More frequent headache-related vertigo (23.0% vs 15.9%)
• Greater difficulty finding words during attacks (43.0% vs 32.9%)
• More severe allodynia and disability scores
• Higher rates of anxiety and depression

Pathophysiology: A Distinct Entity

Post-traumatic headache appears to be a distinct pathophysiological entity rather than simply trauma-triggered primary migraine 7, 8. Key mechanisms include:

• Neuroinflammation and central sensitization driven by microglial and astrocyte activation 2
• Proinflammatory cytokines (IL-1β, TNF-α, IL-6) causing nociceptor sensitization 2
• Dysregulation of CGRP and substance P leading to trigeminovascular sensitization 2
• Autonomic dysfunction and disruption of descending pain modulatory circuits 8
• Epigenetic modifications contributing to pain chronicity 2

Importantly, CGRP levels are not particularly elevated in PTH compared to primary migraine, suggesting different underlying mechanisms despite phenotypic similarities 7.

Diagnostic Considerations

Red flags from head trauma history warrant investigation 9:

• Thunderclap headache
• Atypical aura
• Progressive headache
• Focal neurological symptoms
• Altered consciousness or personality changes

Neuroimaging should only be performed when secondary headache disorders are suspected based on red flags 9. Routine neuroimaging is not indicated for typical post-traumatic headache and can lead to unnecessary alarm from incidental findings.

Critical Timing Issue

Current diagnostic criteria require headache onset within 7 days of injury 10. However, delayed-onset symptoms are common, creating a diagnostic dilemma 10. Clinicians should maintain clinical suspicion for PTH even when symptoms emerge beyond this window.

Important Comorbidities

Post-traumatic stress disorder (PTSD) frequently coexists with PTH, complicating both diagnosis and management 7. Patients with mTBI history also show:

• Higher rates of self-reported physical abuse history (24.3% vs 14.3%) 6
• Greater anxiety and depression symptoms 6
• These psychiatric comorbidities must be addressed concurrently for optimal outcomes

Management Approach

Treatment should be phenotype-guided, using the migraine-like or tension-type presentation to direct therapy 8, 10:

For Migraine-Like PTH:

• First-line acute treatment: NSAIDs (ibuprofen, naproxen, diclofenac) taken early in attack 9
• Second-line acute treatment: Triptans (most effective when taken early, while headache is mild) 9
• Preventive therapy: Consider tricyclic antidepressants or antiepileptics for patients with ≥2 days/month of impairment 11
• Emerging options: CGRP monoclonal antibodies show initial promise in open-label studies 7

Critical Warnings:

• Avoid opioids and barbiturates - questionable efficacy with significant adverse effects and dependency risk 9
• Monitor for medication overuse headache - patients are at high risk given frequent symptom burden 11
• Limit acute medication use to prevent MOH development 9

Multimodal Interventions:

Weak recommendations exist for 4:

• Early information and education about expected recovery
• Graded physical exercise programs
• Vestibular rehabilitation (particularly for those with vertigo)
• Manual treatment of neck and spine
• Psychological treatment
• Interdisciplinary coordinated rehabilitation

Physical rehabilitation and pain-focused cognitive-behavioral therapies benefit patients with persistent symptoms 11.

Key Clinical Pitfalls

1. Assuming PTH is simply "trauma-triggered migraine" - while phenotypically similar, the pathophysiology differs and some patients have pure tension-type presentations 5
2. Failing to screen for psychiatric comorbidities - PTSD, anxiety, and depression significantly impact outcomes and require concurrent treatment 6, 7
3. Overusing acute medications - leads to medication overuse headache, worsening the clinical picture 11
4. Neglecting long-term follow-up - symptoms can persist for months to years, requiring ongoing management 3

Evidence Limitations

The evidence base for PTH-specific treatments remains limited 8, 10. Most recommendations are extrapolated from primary headache disorder studies, as high-quality randomized controlled trials specifically for PTH are lacking. This necessitates a pragmatic approach using established migraine treatments while recognizing PTH's unique features.